Sertoli Treated Cord Blood for Spinal Cord Injury

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$150,000.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43NS050065-01
Agency Tracking Number:
NS050065
Solicitation Year:
2004
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Small Business Information
SANERON CCEL THERAPEUTICS, INC.
3650 Spectrum Blvd., UTC II, Suite 170, TAMPA, FL, 33612
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 CYNDY Davis
 (813) 866-6372
 CDH@SANERON-CCEL.COM
Business Contact
 NICOLE KUZMIN-NICHOLS
Phone: (813) 866-6371
Email: NKN@SANERON-CCEL.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Stem cells from human umbilical cord blood (hUCB) represent a promising cellular therapeutic strategy for the treatment of cord injury (SCI). These cells are capable of differentiating into neurons and glia in vivo

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government